Pluristem Therapeutics (PSTI) Trading Halted with News Pending
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Pluristem Therapeutics (NASDAQ: PSTI) trading halted with news pending. The company is planning to make a "significant" announcement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pluristem Therapeutics (PSTI) Increases Bought Deal Offering of Common Stock and Warrants to $15M
- EnteroMedics (ETRM) Halted on LUDP
- Western Union (WU) Announces Agreements to Resolve U.S. Investigations